Retirement planning is part savings, part guessing game. While many of your day-to-day expenses will remain the same, there are big-ticket categories that can take a large bite out of your savings. Th...
Tag: Pharmaceuticals
Here’s the playbook if the rest of the world breaks free from the U.S. dollar, says Credit Suisse’s monetary plumbing guru
It’s pretty well accepted that no one knows as much about the plumbing of the world’s financial system as Zoltan Pozsar, global head of short-term interest-rate strategy at Credit Suisse, who was the ...
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
Hold Ionis Pharmaceuticals as the share price moved to find a $60 valuation
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is on a bullish streak that began three weeks ago. Last week, the brand reported success in research on a cholesterol drug that it is developing in partnershi...
A big shift is under way for markets, and old Warren Buffett shareholder letters point to which companies will survive
Given a war and inflation have marked the start of 2022, investors would be forgiven for holding their breath over the rest of the year’s offerings. Our call of the day from a team at Saxo Bank sees a...
Discovery, Merck, Carnival, Broadcom, and Other Stocks to Watch This Week
Text size Uncredited It’s a full week of annual shareholder meetings, investor days, and earnings reports. Broadcom hosts its annual meeting on Monday, followed by investor events from Merck, Analog D...
Discovery, Merck, Carnival, Broadcom, and Other Stocks for Investors to Watch This Week
Text size Uncredited It’s a full week of annual shareholder meetings, investor days, and earnings reports. Broadcom hosts its annual meeting on Monday, followed by investor events from Merck, Analog D...
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Biotech stocks took a beating over the past 12 months, but their cheap valuations could be good entry points for investors, experts say. It could also open them up for opportunities to be acquired or ...
Stocks for the Recession That May—or May Not—Be Coming
Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week—and that’s a recession signal that is either like Paul Revere’s...
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access
Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...
Investors have been scared out of this group of stocks, says fund manager, who offers five ideas for the rebound to come.
China has been talking up its markets, and that’s lifting all boats this morning, with Wall Street off to a strong start ahead of what’s expected to be the first Fed rate hike in more than three years...
Cathie Wood Watch: Ark Buys Aerospace, China Car Maker; Sells Pharma
Star investor Cathie Wood, chief executive of Ark Investment Management, remains active in the tumultuous stock market, on Monday buying aerospace and Chinese-vehicle shares. She sold pharmaceutical s...
Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants
Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told...
Covid declared a pandemic two years ago. Health experts warn it’s still not over
Medical staff treat a coronavirus disease (COVID-19) patient in the Intensive Care Unit (ICU) at the Providence Mission Hospital in Mission Viejo, California, January 25, 2022. Shannon Stapleton | Reu...
Novavax’s Revenue Falls Short. Management Expects a Surge.
Text size A doctor handles a vial holding a potential coronavirus vaccine at a Novavax lab in 2020. Andrew Caballero-Reynolds/AFP via Getty Images The Covid-19 vaccine maker Novavax expects sales of b...
Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring
As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...
Moderna Stock Surges On Q4 Earnings Beat, 2022 Vaccine Sales Boost
Updated at 10:06 am EST Moderna (MRNA) – Get Moderna, Inc. Report shares surged Thursday after the drugmaker posted must stronger-than-expected fourth quarter earnings, while boosting its full-...
European stocks and U.S. equity futures wobble as Kremlin says U.S-Russia summit not a done deal
European stocks fell Monday, as investors clung to hopes that diplomacy will prevali over an increasingly tense Russia-Ukraine crisis. Technology stocks led the downside on the heels of sharp losses f...
12 dividend stocks paying at least 3.5% that are well-suited for high inflation
Investors may have turned for a moment from Russia’s aggression in Ukraine to energy and supply shortages in the U.S. that are producing high inflation. With purchasing power crumbling, patient invest...